Bioavailability of cimetidine in man. 1978

S S Walkenstein, and J W Dubb, and W C Randolph, and W J Westlake, and R M Stote, and A P Intoccia

The bioavailability of parenteral cimetidine was tested in 12 volunteers in a balanced three-way crossover study. Blood levels and urinary excretion were compared after intramuscular and intravenous injection and oral administration of 300 mg of cinetidine. The results indicated that the intramuscular and intravenous routes are virtually interchangeable for parenteral cimetidine, and that the oral liquid, although exhibiting a reduced area under the blood level curve as compared with the parenteral doses, nevertheless demonstrated equivalence with respect to the time the blood level remained above 0.5 microgram per ml. The 300-mg cimetidine tablet formulation was found in another group of 12 volunteers to be bioequivalent to a 300-mg dose of oral liquid.

UI MeSH Term Description Entries
D007273 Injections, Intramuscular Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it. Intramuscular Injections,Injection, Intramuscular,Intramuscular Injection
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D002927 Cimetidine A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output. Altramet,Biomet,Biomet400,Cimetidine HCl,Cimetidine Hydrochloride,Eureceptor,Histodil,N-Cyano-N'-methyl-N''-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)ethyl)guanidine,SK&F-92334,SKF-92334,Tagamet,HCl, Cimetidine,Hydrochloride, Cimetidine,SK&F 92334,SK&F92334,SKF 92334,SKF92334
D006146 Guanidines A family of iminourea derivatives. The parent compound has been isolated from mushrooms, corn germ, rice hulls, mussels, earthworms, and turnip juice. Derivatives may have antiviral and antifungal properties.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities

Related Publications

S S Walkenstein, and J W Dubb, and W C Randolph, and W J Westlake, and R M Stote, and A P Intoccia
April 1985, Lancet (London, England),
S S Walkenstein, and J W Dubb, and W C Randolph, and W J Westlake, and R M Stote, and A P Intoccia
November 1979, European journal of clinical pharmacology,
S S Walkenstein, and J W Dubb, and W C Randolph, and W J Westlake, and R M Stote, and A P Intoccia
January 1981, Lancet (London, England),
S S Walkenstein, and J W Dubb, and W C Randolph, and W J Westlake, and R M Stote, and A P Intoccia
March 1981, Lancet (London, England),
S S Walkenstein, and J W Dubb, and W C Randolph, and W J Westlake, and R M Stote, and A P Intoccia
February 1986, Journal of clinical psychopharmacology,
S S Walkenstein, and J W Dubb, and W C Randolph, and W J Westlake, and R M Stote, and A P Intoccia
April 1980, Journal of pharmaceutical sciences,
S S Walkenstein, and J W Dubb, and W C Randolph, and W J Westlake, and R M Stote, and A P Intoccia
January 1979, European journal of clinical pharmacology,
S S Walkenstein, and J W Dubb, and W C Randolph, and W J Westlake, and R M Stote, and A P Intoccia
January 1989, Biopharmaceutics & drug disposition,
S S Walkenstein, and J W Dubb, and W C Randolph, and W J Westlake, and R M Stote, and A P Intoccia
January 1989, Therapeutic drug monitoring,
S S Walkenstein, and J W Dubb, and W C Randolph, and W J Westlake, and R M Stote, and A P Intoccia
February 1981, Clinical pharmacology and therapeutics,
Copied contents to your clipboard!